Fetal gene therapy for neurodegenerative disease of infants.

Nature Medicine
Giulia MassaroAhad A Rahim

Abstract

For inherited genetic diseases, fetal gene therapy offers the potential of prophylaxis against early, irreversible and lethal pathological change. To explore this, we studied neuronopathic Gaucher disease (nGD), caused by mutations in GBA. In adult patients, the milder form presents with hepatomegaly, splenomegaly and occasional lung and bone disease; this is managed, symptomatically, by enzyme replacement therapy. The acute childhood lethal form of nGD is untreatable since enzyme cannot cross the blood-brain barrier. Patients with nGD exhibit signs consistent with hindbrain neurodegeneration, including neck hyperextension, strabismus and, often, fatal apnea1. We selected a mouse model of nGD carrying a loxP-flanked neomycin disruption of Gba plus Cre recombinase regulated by the keratinocyte-specific K14 promoter. Exclusive skin expression of Gba prevents fatal neonatal dehydration. Instead, mice develop fatal neurodegeneration within 15 days2. Using this model, fetal intracranial injection of adeno-associated virus (AAV) vector reconstituted neuronal glucocerebrosidase expression. Mice lived for up to at least 18 weeks, were fertile and fully mobile. Neurodegeneration was abolished and neuroinflammation ameliorated. Neonatal ...Continue Reading

References

Jun 1, 1986·Journal of Microscopy·A J BaddeleyL M Cruz-Orive
May 29, 1999·Journal of Microscopy·H J Gundersen Nielsen J
Dec 25, 2004·Behavioural Brain Research·Andrea LubicsIstván Lengvári
May 24, 2005·Rapid Communications in Mass Spectrometry : RCM·Kevin MillsBryan Winchester
Oct 24, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ida Berglin EnquistStefan Karlsson
Apr 23, 2008·Current Protocols in Neuroscience·R J CarterS B Dunnett
Dec 23, 2008·Nature Biotechnology·Kevin D FoustBrian K Kaspar
Oct 1, 2010·Blood Cells, Molecules & Diseases·N GuptaE Sidransky
Mar 4, 2011·Science Translational Medicine·Marco A PassiniSeng H Cheng
Apr 14, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Steven J GrayR Jude Samulski
Jun 2, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Citra N Z MattarJerry K Y Chan
Jul 13, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ahad A RahimSimon N Waddington
Feb 12, 2013·Seminars in Pediatric Surgery·Erik G Pearson, Alan W Flake
Aug 26, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Christiane Auray-BlaisPamela Lavoie
Oct 7, 2014·Journal of Visualized Experiments : JoVE·Ji-Yoen KimJoanna L Jankowsky
Nov 20, 2014·The New England Journal of Medicine·Amit C NathwaniAndrew M Davidoff
Aug 1, 2015·Prenatal Diagnosis·Jyotsna VermaIshwar C Verma
Oct 2, 2015·The Journal of Clinical Investigation·David A ZeeviAri Zimran
Mar 11, 2017·Human Gene Therapy. Clinical Development·Yoshihide SeharaShin-Ichi Muramatsu
Nov 2, 2017·The New England Journal of Medicine·Jerry R MendellBrian K Kaspar

❮ Previous
Next ❯

Citations

Aug 1, 2018·Nature Reviews. Neurology·Heather Wood
Feb 5, 2019·Journal of Inherited Metabolic Disease·Julien Baruteau, Simon N Waddington
Apr 5, 2019·Molecular Diagnosis & Therapy·Panayiota PapasavvaCarsten W Lederer
Aug 18, 2018·Nature Reviews. Drug Discovery·M Teresa Villanueva
Sep 7, 2019·Autism Research : Official Journal of the International Society for Autism Research·Mark J Zylka
Dec 7, 2019·Human Molecular Genetics·Sophia-Martha Kleine HolthausRobin R Ali
Aug 30, 2019·Molecular Neurodegeneration·Jenny DoEllen Sidransky
Jul 1, 2020·JAMA Pediatrics·Amy E O'ConnellStella Kourembanas
Aug 21, 2020·Proceedings of the National Academy of Sciences of the United States of America·Guoping FengJohn H Morrison
Jun 5, 2019·Nature Medicine·Don P WolfShoukhrat M Mitalipov
Feb 6, 2020·Molecular Diagnosis & Therapy·William H Peranteau, Alan W Flake
Jul 19, 2018·Nature·Heidi Ledford
Jul 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Rachael E SteinWilliam A Catterall
Apr 7, 2020·Nucleic Acids Research·Lingyan WangJohn V Brigande
Aug 9, 2018·Nature Reviews. Neuroscience·Darran Yates
May 7, 2020·Frontiers in Aging Neuroscience·Micol AvenaliSilvia Cerri
Oct 19, 2020·Molecular Neurodegeneration·Karim BelarbiMarie-Christine Chartier-Harlin
Nov 13, 2020·Advanced Drug Delivery Reviews·Rohan PalankiMichael J Mitchell
Jan 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yanan LiuYi Qi
Jan 24, 2021·Molecular Genetics and Metabolism·Emily C DaykinEllen Sidransky
Nov 25, 2020·Neural Regeneration Research·Eric Joshua Garcia, Ellen Sidransky
Dec 6, 2020·Nature Reviews. Drug Discovery·Michael J MitchellRobert Langer
Feb 2, 2021·Science Advances·Rachel S RileyMichael J Mitchell
Jan 29, 2020·Neurobiology of Disease·Rodrigo Vinueza-GavilanesMontserrat Arrasate
Mar 25, 2019·NeuroImage·Lana VasungEmi Takahashi
Oct 2, 2020·Advanced Drug Delivery Reviews·Katherine M NelsonEmily S Day
Mar 14, 2021·Expert Opinion on Pharmacotherapy·Richard SamEllen Sidransky
Apr 10, 2021·Developmental Medicine and Child Neurology·Riccardo PrivolizziJoanne Ng
Apr 27, 2021·International Journal of Pharmaceutics·Guoxin TanWeisan Pan
Jun 29, 2021·Trends in Molecular Medicine·Sourav K BoseWilliam H Peranteau
Jul 3, 2021·International Journal of Molecular Sciences·Jenny DoEllen Sidransky
Jul 15, 2021·Nature Communications·Sourav K BoseWilliam H Peranteau
Oct 27, 2020·Current Topics in Medicinal Chemistry·Josep GarciaMeritxell Teixidó
Jul 31, 2021·Human Reproduction Update·Lidiia ZhytnikAndres Salumets

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
transfection
cesarean section

Software Mentioned

Leica
LAS
Image Pro - Plus

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.